Commutee

J&J ordered to pay $417 million in trial over talc cancer risks

August 21, 2017 by  
Filed under News

(Reuters) – Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.


Source: Reuters Business News

Comments are closed.